Grob D, Brunner N, Namba T, Pagala M. Lifetime course of myasthenia gravis. Muscle Nerve. 2008;37:141–9.
Galassi G, Mazzoli M, Ariatti A, Kaleci S, Valzania F, Nichelli PF. Antibody profile may predict outcome in ocular myasthenia gravis. Acta Neurol Belg. 2018;118:435–43.
Nagaishi A, Narita T, Woodhall M, Jacobson L, Waters P, Irani SR, et al. Autoantibodies in Japanese patients with ocular myasthenia gravis. Muscle Nerve. 2021;63:262–7.
Article CAS PubMed Google Scholar
Birmanns B, Brenner T, Abramsky O, Steiner I. Seronegative myasthenia gravis: clinical features, response to therapy and synthesis of acetylcholine receptor antibodies in vitro. J Neurol Sci. 1991;102:184–9.
Article CAS PubMed Google Scholar
Evoli A, Batocchi AP, Lo Monaco M, Servidei S, Padua L, Majolini L, et al. Clinical heterogeneity of seronegative myasthenia gravis. Neuromuscul Disord. 1996;6:155–61.
Article CAS PubMed Google Scholar
Guterman EL, Botelho JV, Horton JC. Diagnosis of Tensilon-negative ocular myasthenia Gravis by Daily Selfie. J Neuroophthalmol. 2016;36:292–3.
Article PubMed PubMed Central Google Scholar
Mao ZF, Yang LX, Mo XA, Qin C, Lai YR, He NY, et al. Frequency of autoimmune diseases in myasthenia gravis: a systematic review. Int J Neurosci. 2011;121:121–9.
Kubiszewska J, Szyluk B, Szczudlik P, Bartoszewicz Z, Dutkiewicz M, Bielecki M, et al. Prevalence and impact of autoimmune thyroid disease on myasthenia gravis course. Brain Behav. 2016;6:e00537.
Article PubMed PubMed Central Google Scholar
Ratanakorn D, Vejjajiva A. Long-term follow-up of myasthenia gravis patients with hyperthyroidism. Acta Neurol Scand. 2002;106:93–8.
Article CAS PubMed Google Scholar
Sahay BM, Blendis LM, Greene R. Relation between myasthenia gravis and thyroid disease. Br Med J. 1965;1:762–5.
Article CAS PubMed PubMed Central Google Scholar
Kiessling WR, Pflughaupt KW, Ricker K, Haubitz I, Mertens HG. Thyroid function and circulating antithyroid antibodies in myasthenia gravis. Neurology. 1981;31:771–4.
Article CAS PubMed Google Scholar
Toth C, McDonald D, Oger J, Brownell K. Acetylcholine receptor antibodies in myasthenia gravis are associated with greater risk of diabetes and thyroid disease. Acta Neurol Scand. 2006;114:124–32.
Article CAS PubMed Google Scholar
Lopomo A, Berrih-Aknin S. Autoimmune thyroiditis and Myasthenia Gravis. Front Endocrinol (Lausanne). 2017;8:169.
Sun L, Meng Y, Xie Y, Zhang H, Zhang Z, Wang X, et al. CTLA4 variants and haplotype contribute genetic susceptibility to myasthenia gravis in northern Chinese population. PLoS ONE. 2014;9:e101986.
Article PubMed PubMed Central Google Scholar
Claytor B, Li Y. Challenges in diagnosing coexisting ocular myasthenia gravis and thyroid eye disease. Muscle Nerve. 2021;63:631–9.
Vargas ME, Warren FA, Kupersmith MJ. Exotropia as a sign of myasthenia gravis in dysthyroid ophthalmopathy. Br J Ophthalmol. 1993;77:822–3.
Article CAS PubMed PubMed Central Google Scholar
Chatzistefanou KI, Kouris T, Iliakis E, Piaditis G, Tagaris G, Katsikeris N, et al. The ice pack test in the differential diagnosis of myasthenic diplopia. Ophthalmology. 2009;116:2236–43.
An R, Li Y, Yang B, Wang H, Xu Y. Rare co-occurrence of ocular myasthenia gravis and thyroid-Associated Orbitopathy (Ophthalmopathy) in an individual with hypothyroidism. Front Endocrinol (Lausanne). 2018;9:801.
Evoli A, Bianchi MR, Riso R, Minicuci GM, Batocchi AP, Servidei S, et al. Response to therapy in myasthenia gravis with anti-MuSK antibodies. Ann N Y Acad Sci. 2008;1132:76–83.
Article CAS PubMed Google Scholar
Hamedani AG, Pistilli M, Singhal S, Shindler KS, Avery RA, Tamhankar MA. Outcomes after Transcervical Thymectomy for Ocular Myasthenia gravis: a Retrospective Cohort Study with Inverse Probability Weighting. J Neuroophthalmol. 2020;40:8–14.
Article PubMed PubMed Central Google Scholar
Roberts PF, Venuta F, Rendina E, De Giacomo T, Coloni GF, Follette DM, et al. Thymectomy in the treatment of ocular myasthenia gravis. J Thorac Cardiovasc Surg. 2001;122:562–8.
Article CAS PubMed Google Scholar
Liu X, Zhou W, Hu J, Hu M, Gao W, Zhang S, Zeng W. Prognostic predictors of remission in ocular myasthenia after thymectomy. J Thorac Dis. 2020;12:422–30.
Article PubMed PubMed Central Google Scholar
Peeler CE, De Lott LB, Nagia L, Lemos J, Eggenberger ER, Cornblath WT. Clinical utility of acetylcholine receptor antibody testing in Ocular Myasthenia Gravis. JAMA Neurol. 2015;72:1170–4.
Comments (0)